Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retatrutide in obesity or overweight with comorbidities
NCT07467447Phase 2Recruiting
- Sponsor
- Hudson Biotech
- Start
- Feb 2026
- Primary completion
- Mar 2027
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of retatrutide in obesity, sponsored by Hudson Biotech. Started Feb 2026; status: recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07467447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07467447.